Influenza vaccination: A new indication of an old therapy?;Vacunación antigripal: ¿ nuevas indicaciones de un antiguo tratamiento?

Revista Espanola de Cardiologia

Volumn 56, Issue 10, 2003, Pages 944-946

  García Moll, Xavier ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ATHEROSCLEROSIS; CLINICAL STUDY; EDITORIAL; HUMAN; INFLAMMATION; INFLUENZA VACCINATION; ISCHEMIC HEART DISEASE; TREATMENT INDICATION; ARTERIOSCLEROSIS; HEART MUSCLE ISCHEMIA; NOTE;

ARTERIOSCLEROSIS; HUMANS; INFLUENZA VACCINES; MYOCARDIAL ISCHEMIA;

EID: 0242522293     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13052380     Document Type: Editorial

References (13)

1. Nicoletti A, Caligiuri G, Paulsson G, Hansson GK. Functionality of specific immunity in atherosclerosis. Am Heart J 1999;138: S438-43.
2. Danesh J. Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia penumoniae, and Cytomegalovirus: meta-analyses of prospective studies. Am Heart J 1999;138:S434-7.
3. Bloemenkamp DG, Mali WP, Visseren FL, van der Graaf Y. Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results? Am Heart J 2003;145:409-17.
4. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol 1998; 31:827-32.
5. Woodhouse PR, Khaw KT, Plummer M, Foley A, Meade TW. Seasonal variations of plasma fibrinogen, and factor VII activity en the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343:435-9.
6. Binder CJ, Horkko S, Dewan A, Chang MK, Kicu EP, Goodyear CS, et al. Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat Med 2003;9:736-43.
7. Palinski W, Miller E, Witztum JL. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits With homologous malondialdehyde LDL reduces atherogenesis. Proc Natl Acad Sci USA 1995;92:821-5.
8. Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2002;102:3039-45
9. Jackson LA, Yu O, Heckbert SR, Psaty BM, Malais D, Barlow WE, et al, for the Vaccine Safety Datalink Study Group. Influenza vaccination is not associated with a reduction in the risk of recurrent coronary events. Am J Epidemiol 2002;156:634-40.
10. Hansson GK. Vaccination against atherosclerosis: science or fiction? Circulation 2002;106:1599-601.
11. Nichol KL, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M. Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med 2003; 348:1322-32.
12. León de la Fuente R, Gurfinkel EP, Toledo D, Mautner B. Vacunación antigripal en pacientes con síndromes coronarios agudos: beneficio del tratamiento en diferentes subgrupos. Rev Esp Cardiol 2003;56:949-54.
13. Gurfinkel EP, de la Fuente RL, Mendiz O, Mautner B. Influenza vaccine pilot study in acute coronary syndromes and planned percutaneous coronary interventions: the FLU Vaccination Acute Coronary Syndromes (FLUVACS) Study. Circulation 2002;105: 2143-7.